This article was originally published in The Rose Sheet
Executive SummaryDen-Mat will change Rembrandt ads and packaging to reflect new U.S. patent approval for toothpaste, gel-paste compositions that contain "bio-active" peroxide, oral care manufacturer states. Ads, packaging will include patent number and state "patented formula," company maintains. Den-Mat active peroxide-containing toothpastes and gels include Rembrandt Plus with Peroxide toothpaste and gel, Rembrandt Age Defying Toothpaste and Rembrandt Dazzling White bleaching system...
You may also be interested in...
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced October to November.
The French drugmaker is paying $2.5bn to get hold of THOR-707 which it claims has the potential to become the best-in-class IL-2 therapeutic for solid tumors, thanks to improved pharmacology and less frequent dosing.
For the first time, a working group within the International Council for Harmonization has started work on a regulatory topic specifically tailored to the global generics and biosimilars industry.